Oramed Pharmaceuticals Inc. (ORMP)

Oramed Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY
Period Ending	Apr 17, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Aug 31, 2012
Market Cap	157	112	97	93	476	26
Market Cap Growth	74.56%	15.87%	3.67%	-80.42%	1757.13%	26.04%
Enterprise Value	23.49	-18.06	-46.09	-18.44	320.23	20.54
Last Close Price	3.88	2.85	2.42	2.31	12.03	3.84
PE Ratio	2.59	1.90	-5.04	16.50	-12.80	-6.74
PS Ratio	78.47	55.97	-	69.54	176.08	-
PB Ratio	0.76	0.56	0.66	0.57	3.14	6.78
P/TBV Ratio	0.81	0.61	0.68	0.57	3.09	5.98
P/FCF Ratio	-	-12.23	-11.46	-8.83	-16.75	-11.12
P/OCF Ratio	-	-12.24	-11.48	-9.05	-17.05	-11.13
EV/Sales Ratio	11.75	-9.03	-	-13.76	118.47	-
EV/EBITDA Ratio	-	1.21	3.66	1.18	-7.90	7.09
EV/EBIT Ratio	-	1.20	3.61	1.17	-7.89	7.12
EV/FCF Ratio	-	1.97	5.47	1.75	-11.27	-8.92
Debt / Equity Ratio	0.00	0.00	0.00	0.32	0.00	0
Debt / EBITDA Ratio	-0.05	-0.05	-0.03	-3.31	-0.02	-
Debt / FCF Ratio	-0.09	-0.09	-0.04	-4.89	-0.03	-
Net Debt / Equity Ratio	-0.65	-0.65	-0.97	-0.67	-1.02	-1.35
Net Debt / EBITDA Ratio	8.67	8.67	11.25	7.09	3.82	-1.75
Net Debt / FCF Ratio	14.17	14.17	16.79	10.47	5.45	2.21
Asset Turnover	0.01	0.01	0	0.01	0.02	0
Quick Ratio	6.84	6.84	24.97	3.05	27.10	8.16
Current Ratio	6.98	6.98	25.19	3.06	27.34	8.19
Return on Equity (ROE)	37.10%	37.10%	-12.39%	3.24%	-24.98%	177.05%
Return on Assets (ROA)	-6.64%	-6.64%	-8.16%	-8.25%	-25.18%	111.96%
Return on Invested Capital (ROIC)	-25.30%	-25.30%	-47.59%	-54.07%	-2308.89%	-1362.72%
Return on Capital Employed (ROCE)	-8.35%	-8.35%	-8.07%	-9.76%	-26.04%	124.03%
Earnings Yield	40.30%	52.63%	-19.83%	6.06%	-7.81%	-14.84%
FCF Yield	-5.83%	-8.18%	-8.73%	-11.32%	-5.97%	-8.99%
Buyback Yield / Dilution	-3.84%	-3.84%	-0.70%	-4.02%	-562.71%	-8.63%
Total Shareholder Return	-3.84%	-3.84%	-0.70%	-4.02%	-562.71%	-8.63%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q